| Metric | Count |
|---|---|
| Total Survey Responses Before Deduplication | 3625 |
| Field | Value | Number of Submissions |
|---|---|---|
| IP Address | 108.205.171.174 | 4 |
| IP Address | 72.192.72.107 | 4 |
| IP Address | 75.182.92.102 | 4 |
| IP Address | 107.138.187.161 | 3 |
| IP Address | 107.77.234.232 | 3 |
| IP Address | 138.43.171.67 | 3 |
| IP Address | 172.74.28.201 | 3 |
| IP Address | 23.127.69.109 | 3 |
| IP Address | 23.226.173.120 | 3 |
| IP Address | 64.178.232.163 | 3 |
| IP Address | 66.148.36.217 | 3 |
| IP Address | 71.207.14.94 | 3 |
| IP Address | 72.47.39.120 | 3 |
| IP Address | 73.40.99.88 | 3 |
| IP Address | 99.114.156.254 | 3 |
| IP Address | 104.151.215.179 | 2 |
| IP Address | 104.178.89.224 | 2 |
| IP Address | 107.134.11.214 | 2 |
| IP Address | 107.196.78.150 | 2 |
| IP Address | 107.77.201.68 | 2 |
| IP Address | 107.77.203.79 | 2 |
| IP Address | 107.77.206.60 | 2 |
| IP Address | 107.77.207.66 | 2 |
| IP Address | 107.77.233.42 | 2 |
| IP Address | 107.77.236.141 | 2 |
| IP Address | 108.185.225.206 | 2 |
| IP Address | 108.216.32.210 | 2 |
| IP Address | 108.243.155.150 | 2 |
| IP Address | 130.45.136.95 | 2 |
| IP Address | 135.84.224.37 | 2 |
| IP Address | 137.119.54.85 | 2 |
| IP Address | 138.207.188.215 | 2 |
| IP Address | 154.73.221.120 | 2 |
| IP Address | 155.4.54.179 | 2 |
| IP Address | 156.146.74.196 | 2 |
| IP Address | 162.194.112.237 | 2 |
| IP Address | 162.245.50.28 | 2 |
| IP Address | 166.137.83.8 | 2 |
| IP Address | 166.182.86.80 | 2 |
| IP Address | 166.196.110.19 | 2 |
| IP Address | 170.199.182.183 | 2 |
| IP Address | 170.199.186.70 | 2 |
| IP Address | 170.52.178.154 | 2 |
| IP Address | 172.11.253.41 | 2 |
| IP Address | 172.56.58.11 | 2 |
| IP Address | 173.242.245.200 | 2 |
| IP Address | 173.25.6.226 | 2 |
| IP Address | 174.223.140.44 | 2 |
| IP Address | 174.226.132.95 | 2 |
| IP Address | 174.24.170.62 | 2 |
| IP Address | 174.57.89.18 | 2 |
| IP Address | 174.66.24.27 | 2 |
| IP Address | 184.105.1.62 | 2 |
| IP Address | 184.155.49.129 | 2 |
| IP Address | 184.20.116.43 | 2 |
| IP Address | 192.240.53.52 | 2 |
| IP Address | 198.133.9.30 | 2 |
| IP Address | 204.111.133.170 | 2 |
| IP Address | 206.246.24.87 | 2 |
| IP Address | 207.174.224.76 | 2 |
| IP Address | 208.118.207.116 | 2 |
| IP Address | 208.86.8.112 | 2 |
| IP Address | 208.95.65.85 | 2 |
| IP Address | 213.205.241.255 | 2 |
| IP Address | 216.105.185.233 | 2 |
| IP Address | 216.14.159.196 | 2 |
| IP Address | 216.222.140.121 | 2 |
| IP Address | 220.236.163.217 | 2 |
| IP Address | 23.122.4.123 | 2 |
| IP Address | 23.226.163.185 | 2 |
| IP Address | 24.107.71.116 | 2 |
| IP Address | 24.126.14.149 | 2 |
| IP Address | 24.145.113.12 | 2 |
| IP Address | 24.15.157.4 | 2 |
| IP Address | 24.159.77.155 | 2 |
| IP Address | 24.189.245.94 | 2 |
| IP Address | 24.244.102.220 | 2 |
| IP Address | 24.245.102.146 | 2 |
| IP Address | 24.254.26.117 | 2 |
| IP Address | 24.255.254.47 | 2 |
| IP Address | 24.44.42.108 | 2 |
| IP Address | 24.88.4.99 | 2 |
| IP Address | 32.211.10.132 | 2 |
| IP Address | 47.132.177.155 | 2 |
| IP Address | 47.134.45.242 | 2 |
| IP Address | 47.214.52.54 | 2 |
| IP Address | 47.232.118.211 | 2 |
| IP Address | 47.40.12.191 | 2 |
| IP Address | 47.44.49.212 | 2 |
| IP Address | 50.55.60.104 | 2 |
| IP Address | 64.130.186.133 | 2 |
| IP Address | 64.15.81.186 | 2 |
| IP Address | 64.250.68.168 | 2 |
| IP Address | 65.245.183.66 | 2 |
| IP Address | 65.28.67.224 | 2 |
| IP Address | 66.186.109.226 | 2 |
| IP Address | 66.196.1.34 | 2 |
| IP Address | 66.38.29.119 | 2 |
| IP Address | 66.86.45.22 | 2 |
| IP Address | 67.187.106.94 | 2 |
| IP Address | 67.187.80.40 | 2 |
| IP Address | 67.45.32.29 | 2 |
| IP Address | 67.6.169.164 | 2 |
| IP Address | 67.81.1.214 | 2 |
| IP Address | 67.83.2.89 | 2 |
| IP Address | 68.186.171.227 | 2 |
| IP Address | 68.193.136.245 | 2 |
| IP Address | 68.33.48.251 | 2 |
| IP Address | 69.10.111.142 | 2 |
| IP Address | 69.10.118.1 | 2 |
| IP Address | 69.10.120.186 | 2 |
| IP Address | 69.10.96.213 | 2 |
| IP Address | 69.141.224.163 | 2 |
| IP Address | 69.244.193.69 | 2 |
| IP Address | 69.248.222.40 | 2 |
| IP Address | 69.255.102.49 | 2 |
| IP Address | 69.71.12.132 | 2 |
| IP Address | 69.8.168.193 | 2 |
| IP Address | 70.161.175.147 | 2 |
| IP Address | 70.178.126.157 | 2 |
| IP Address | 70.178.248.78 | 2 |
| IP Address | 71.1.99.201 | 2 |
| IP Address | 71.153.14.149 | 2 |
| IP Address | 71.214.68.167 | 2 |
| IP Address | 71.217.191.142 | 2 |
| IP Address | 71.62.240.131 | 2 |
| IP Address | 71.69.181.253 | 2 |
| IP Address | 72.192.86.27 | 2 |
| IP Address | 72.204.100.183 | 2 |
| IP Address | 72.206.8.232 | 2 |
| IP Address | 72.224.178.101 | 2 |
| IP Address | 72.45.14.70 | 2 |
| IP Address | 73.104.219.114 | 2 |
| IP Address | 73.12.44.29 | 2 |
| IP Address | 73.12.54.149 | 2 |
| IP Address | 73.134.191.236 | 2 |
| IP Address | 73.134.39.6 | 2 |
| IP Address | 73.177.249.58 | 2 |
| IP Address | 73.185.226.92 | 2 |
| IP Address | 73.187.131.250 | 2 |
| IP Address | 73.195.49.221 | 2 |
| IP Address | 73.217.140.115 | 2 |
| IP Address | 73.226.196.54 | 2 |
| IP Address | 73.31.112.217 | 2 |
| IP Address | 73.31.161.171 | 2 |
| IP Address | 73.33.39.97 | 2 |
| IP Address | 73.42.57.51 | 2 |
| IP Address | 73.99.43.32 | 2 |
| IP Address | 74.51.1.54 | 2 |
| IP Address | 74.81.111.54 | 2 |
| IP Address | 74.96.106.111 | 2 |
| IP Address | 75.105.194.239 | 2 |
| IP Address | 75.107.232.246 | 2 |
| IP Address | 75.186.107.150 | 2 |
| IP Address | 75.189.131.81 | 2 |
| IP Address | 75.23.158.45 | 2 |
| IP Address | 76.119.76.211 | 2 |
| IP Address | 76.20.246.39 | 2 |
| IP Address | 76.23.83.168 | 2 |
| IP Address | 76.251.41.93 | 2 |
| IP Address | 96.67.90.173 | 2 |
| IP Address | 97.88.201.59 | 2 |
| IP Address | 98.166.202.17 | 2 |
| IP Address | 98.186.117.133 | 2 |
| IP Address | 98.187.134.183 | 2 |
| IP Address | 99.179.114.237 | 2 |
| IP Address | 99.197.253.84 | 2 |
| IP Address | 99.98.82.144 | 2 |
Confirmed: No duplicate IP Addresses remain after deduplication. ## 186 duplicated IP Addresses were removed keeping only the first response entered using Start Date
| Metric | Count |
|---|---|
| Total Survey Responses After Deduplication | 3437 |
| Statistic | DF | P_Value | |
|---|---|---|---|
| X-squared | 325.14 | 5 | < 1e-05 |
Conclusion - There is a significant difference in the number of survey responses between years. - The differences are not due to random variation. - Some years had much higher or much lower response counts than expected.
| Response | Count | Percent |
|---|---|---|
| No | 695 | 100 |
n
= 1594 displayed | 45 values above 100 kU/L excluded from chart Total n
= 1639
| Year | Response Bin | Count | Percentage (%) |
|---|---|---|---|
| 2024 | 0-9 | 132 | 12.8 |
| 2023 | 0-9 | 258 | 25.1 |
| 2022 | 0-9 | 253 | 24.6 |
| 2021 | 0-9 | 64 | 6.2 |
| 2020 | 0-9 | 147 | 14.3 |
| 2019 | 0-9 | 175 | 17.0 |
| 2024 | 10-19 | 17 | 10.1 |
| 2023 | 10-19 | 31 | 18.3 |
| 2022 | 10-19 | 34 | 20.1 |
| 2021 | 10-19 | 15 | 8.9 |
| 2020 | 10-19 | 34 | 20.1 |
| 2019 | 10-19 | 38 | 22.5 |
| 2024 | 20-29 | 6 | 5.8 |
| 2023 | 20-29 | 21 | 20.2 |
| 2022 | 20-29 | 30 | 28.8 |
| 2021 | 20-29 | 11 | 10.6 |
| 2020 | 20-29 | 20 | 19.2 |
| 2019 | 20-29 | 16 | 15.4 |
| 2024 | 30-39 | 8 | 10.5 |
| 2023 | 30-39 | 23 | 30.3 |
| 2022 | 30-39 | 15 | 19.7 |
| 2021 | 30-39 | 4 | 5.3 |
| 2020 | 30-39 | 6 | 7.9 |
| 2019 | 30-39 | 20 | 26.3 |
| 2024 | 40-49 | 3 | 5.8 |
| 2023 | 40-49 | 14 | 26.9 |
| 2022 | 40-49 | 12 | 23.1 |
| 2021 | 40-49 | 3 | 5.8 |
| 2020 | 40-49 | 11 | 21.2 |
| 2019 | 40-49 | 9 | 17.3 |
| 2024 | 50-59 | 6 | 13.0 |
| 2023 | 50-59 | 8 | 17.4 |
| 2022 | 50-59 | 10 | 21.7 |
| 2021 | 50-59 | 4 | 8.7 |
| 2020 | 50-59 | 12 | 26.1 |
| 2019 | 50-59 | 6 | 13.0 |
| 2024 | 60-69 | 2 | 6.7 |
| 2023 | 60-69 | 5 | 16.7 |
| 2022 | 60-69 | 10 | 33.3 |
| 2020 | 60-69 | 5 | 16.7 |
| 2019 | 60-69 | 8 | 26.7 |
| 2024 | 70-79 | 5 | 17.2 |
| 2023 | 70-79 | 10 | 34.5 |
| 2022 | 70-79 | 6 | 20.7 |
| 2021 | 70-79 | 1 | 3.4 |
| 2020 | 70-79 | 5 | 17.2 |
| 2019 | 70-79 | 2 | 6.9 |
| 2024 | 80-89 | 1 | 4.3 |
| 2023 | 80-89 | 4 | 17.4 |
| 2022 | 80-89 | 5 | 21.7 |
| 2021 | 80-89 | 2 | 8.7 |
| 2020 | 80-89 | 3 | 13.0 |
| 2019 | 80-89 | 8 | 34.8 |
| 2024 | 90-99 | 4 | 13.8 |
| 2023 | 90-99 | 9 | 31.0 |
| 2022 | 90-99 | 3 | 10.3 |
| 2021 | 90-99 | 3 | 10.3 |
| 2020 | 90-99 | 4 | 13.8 |
| 2019 | 90-99 | 6 | 20.7 |
n
= 1587
| Response Bin | Count | Percentage (%) |
|---|---|---|
| <0.1 | 13 | 0.8 |
| 0.1-1.9 | 590 | 36.0 |
| 2.0-9.9 | 433 | 26.4 |
| >10 | 603 | 36.8 |
n = 1639
| Statistic | Value |
|---|---|
| Mean | 18.78 |
| Median | 3.33 |
| Mode | 0.1 |
| Standard Deviation | 58.63 |
| Range | 0 - 896 |
| 34 values above 100 kU/L excluded from chart |
Total n = 1496
n
= 1442
| Response Bin | Count | Percentage (%) |
|---|---|---|
| <0.1 | 30 | 2.0 |
| 0.1-1.9 | 583 | 38.8 |
| 2.0-9.9 | 410 | 27.3 |
| >10 | 480 | 31.9 |
| GENDER | Count | Percentage |
|---|---|---|
| FEMALE | 1885 | 81.53 |
| MALE | 427 | 18.47 |
n=
2312
| RACE | Count | Percentage |
|---|---|---|
| WHITE | 2174 | 95.81 |
| AMERICAN INDIAN OR ALASKA NATIVE | 48 | 2.12 |
| UNKNOWN | 21 | 0.93 |
| BLACK OR AFRICAN AMERICAN | 10 | 0.44 |
| ASIAN | 9 | 0.40 |
| NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER | 7 | 0.31 |
n=
2269
| ETHNICITY | Count | Percentage |
|---|---|---|
| NOT HISPANIC OR LATINO | 2105 | 93.64 |
| UNKNOWN | 96 | 4.27 |
| HISPANIC OR LATINO | 47 | 2.09 |
n=
2248
| EDUCATION | Count | Percentage |
|---|---|---|
| BACHELORS | 622 | 27.56 |
| SOME COLLEGE | 427 | 18.92 |
| MASTERS | 365 | 16.17 |
| ASSOCIATES | 245 | 10.86 |
| HIGHSCHOOL OR EQUIVALENT | 230 | 10.19 |
| TRADE/TECHNICAL/VOCATIONAL | 172 | 7.62 |
| DOCTORATE | 73 | 3.23 |
| PROFESSIONAL DEGREE | 67 | 2.97 |
| SOME HIGHSCHOOL | 56 | 2.48 |
n=
2257
| AGE_RANGE | Count | Percentage |
|---|---|---|
| 55-64 | 653 | 28.70 |
| 45-54 | 639 | 28.09 |
| 65+ | 390 | 17.14 |
| 35-44 | 384 | 16.88 |
| 25-34 | 154 | 6.77 |
| 18-24 | 55 | 2.42 |
n=
2275
| HOUSEHOLD_INCOME | Count | Percentage |
|---|---|---|
| BETWEEN $100,000 AND $150,000 | 450 | 22.08 |
| BETWEEN $50,000 AND $74,999 | 409 | 20.07 |
| BETWEEN $75,000 AND $99,999 | 338 | 16.58 |
| OVER $150,000 | 307 | 15.06 |
| BETWEEN $30,000 AND $49,999 | 288 | 14.13 |
| BETWEEN $15,000 AND $29,999 | 163 | 8.00 |
| UNDER $15,000 | 83 | 4.07 |
n=
2038
| Statistic | Value |
|---|---|
| Mean | 45.26 |
| Standard Deviation | 15.96 |
| Range | 0 - 85 |
| Age_Group | Count |
|---|---|
| 10-19 | 9 |
| 20-29 | 241 |
| 30-39 | 378 |
| 40-49 | 652 |
| 50-59 | 580 |
| 60-69 | 397 |
| 70-79 | 102 |
| 80-89 | 11 |
n
= 2370
| Statistic | Value |
|---|---|
| Mean | 49.57 |
| Standard Deviation | 13.84 |
| Range | 3 - 86 |
| Age | Count | Percentage (%) |
|---|---|---|
| 60 | 90 | 2.62 |
| 52 | 89 | 2.59 |
| 50 | 82 | 2.39 |
| 59 | 78 | 2.27 |
| 47 | 77 | 2.24 |
| 48 | 74 | 2.15 |
| 49 | 74 | 2.15 |
| 45 | 72 | 2.10 |
| 55 | 71 | 2.07 |
| 46 | 70 | 2.04 |
| 54 | 69 | 2.01 |
| 58 | 69 | 2.01 |
| 57 | 67 | 1.95 |
| 63 | 65 | 1.89 |
| 65 | 65 | 1.89 |
| 42 | 64 | 1.86 |
| 53 | 64 | 1.86 |
| 43 | 63 | 1.83 |
| 62 | 63 | 1.83 |
| 51 | 61 | 1.78 |
| 40 | 59 | 1.72 |
| 44 | 59 | 1.72 |
| 56 | 59 | 1.72 |
| 61 | 52 | 1.51 |
| 38 | 50 | 1.46 |
| 39 | 50 | 1.46 |
| 41 | 48 | 1.40 |
| 64 | 47 | 1.37 |
| 36 | 44 | 1.28 |
| 66 | 41 | 1.19 |
| 69 | 41 | 1.19 |
| 37 | 39 | 1.14 |
| 35 | 37 | 1.08 |
| 67 | 33 | 0.96 |
| 70 | 30 | 0.87 |
| 34 | 28 | 0.81 |
| 71 | 28 | 0.81 |
| 29 | 24 | 0.70 |
| 68 | 24 | 0.70 |
| 27 | 23 | 0.67 |
| 32 | 23 | 0.67 |
| 72 | 22 | 0.64 |
| 30 | 20 | 0.58 |
| 33 | 20 | 0.58 |
| 28 | 18 | 0.52 |
| 25 | 16 | 0.47 |
| 31 | 16 | 0.47 |
| 24 | 15 | 0.44 |
| 74 | 14 | 0.41 |
| 21 | 12 | 0.35 |
| 26 | 12 | 0.35 |
| 73 | 12 | 0.35 |
| 75 | 11 | 0.32 |
| 22 | 10 | 0.29 |
| 23 | 10 | 0.29 |
| 19 | 7 | 0.20 |
| 20 | 6 | 0.17 |
| 76 | 6 | 0.17 |
| 77 | 6 | 0.17 |
| 79 | 3 | 0.09 |
| 80 | 3 | 0.09 |
| 83 | 3 | 0.09 |
| 78 | 2 | 0.06 |
| 82 | 2 | 0.06 |
| 85 | 2 | 0.06 |
| 81 | 1 | 0.03 |
| 86 | 1 | 0.03 |
n
= 2516
| Additional Tickborne Diagnosis | Count | Percentage |
|---|---|---|
| NONE | 2010 | 75.17 |
| LYME (BORRELIA BURGDORFERI) | 321 | 12.00 |
| RICKETTSIAS AND/OR ROCKY MOUNTAIN SPOTTED FEVER | 204 | 7.63 |
| EHRLICHIOSIS | 55 | 2.06 |
| BABESIA | 45 | 1.68 |
| STARI (SOUTHERN TICK-ASSOCIATED RASH ILLNESS) | 25 | 0.93 |
| ANAPLASMOSIS | 5 | 0.19 |
| HEARTLAND VIRUS | 4 | 0.15 |
| BORRELIA MAYONNI | 3 | 0.11 |
| BORRELIA MIYAMOTOI | 2 | 0.07 |
n
= 2257
| Type of Healthcare Provider Diagnosis | Count | Percentage |
|---|---|---|
| ALLERGIST | 1227 | 53.60 |
| PRIMARY CARE PROVIDER (MD OR DO) | 702 | 30.67 |
| NURSE PRACTITIONER | 154 | 6.73 |
| GASTROENTEROLOGIST | 109 | 4.76 |
| IMMUNOLOGIST | 45 | 1.97 |
| PHYSICIAN ASSISTANT | 36 | 1.57 |
| OBSTETRICIAN/GYNECOLOGIST | 5 | 0.22 |
| CARDIOLOGIST | 3 | 0.13 |
| ENDOCRINOLOGIST | 3 | 0.13 |
| PEDIATRICIAN | 3 | 0.13 |
| DENTIST | 2 | 0.09 |
n
= 2362
| Mammal Ingredient Reaction | Count | Percentage |
|---|---|---|
| BEEF | 2423 | 97.70 |
| PORK | 2163 | 87.22 |
| DAIRY | 1656 | 66.77 |
| GELATIN (FOOD OR MEDICINE E.G. GEL CAPS) | 1519 | 61.25 |
| PERSONAL CARE PRODUCTS (E.G. TAMPONS, COSMETICS, SHAMPOO, LOTIONS) | 1042 | 42.02 |
| PRESCRIPTION MEDICATIONS | 1024 | 41.29 |
| OVER-THE-COUNTER MEDICATIONS | 903 | 36.41 |
| LAMB | 841 | 33.91 |
| HOUSEHOLD PRODUCTS (E.G. CLEANING PRODUCTS, LAUNDRY DETERGENT, OR DRYER SHEETS) | 798 | 32.18 |
| VENISON | 772 | 31.13 |
| VACCINATIONS | 384 | 15.48 |
| DENTAL/SURGICAL MEDICAL SUPPLIES | 323 | 13.02 |
| TEXTILES | 309 | 12.46 |
n
= 2558
| Number of Reactions Prior to Diagnosis | Count | Percentage |
|---|---|---|
| NONE | 37 | 100 |
n = 37
n
= 37
| Medical Intervention | Count | Percentage (%) |
|---|---|---|
| NONE OF THE ABOVE | 1878 | 54.66 |
| VISITED THE EMERGENCY ROOM | 935 | 27.21 |
| VISITED AN URGENT CARE FACILITY | 257 | 7.48 |
| SELF-ADMINISTERED AN EPI-PEN | 159 | 4.63 |
| ADMITTED TO THE HOSPITAL | 153 | 4.45 |
| ADMITTED TO THE INTENSIVE CARE UNIT (ICU) | 54 | 1.57 |
n
= 3436
| Additional Allergy | Count | Percentage (%) |
|---|---|---|
| NONE OF THE ABOVE | 2116 | 61.58 |
| MEATS | 833 | 24.24 |
| DAIRY (COW/SHEEP/GOAT MILK, CHEESE, YOGURT, ETC.) | 722 | 21.01 |
| WHEAT (GLUTEN) | 276 | 8.03 |
| CARAGEENAN | 264 | 7.68 |
| SHELLFISH | 194 | 5.65 |
| EGG | 181 | 5.27 |
| PEANUT | 164 | 4.77 |
| TREE NUTS | 164 | 4.77 |
| FRUITS | 115 | 3.35 |
| SOY | 115 | 3.35 |
| SESAME/SESAME SEEDS | 87 | 2.53 |
| VEGETABLES | 87 | 2.53 |
| CEREALS & GRAINS | 74 | 2.15 |
| BEANS, LEGUMES, PULSES | 65 | 1.89 |
| FINNED FISH | 43 | 1.25 |
n
= 3436
| Exposure | Count | Percentage (%) |
|---|---|---|
| HOME | 2224 | 64.73 |
| RESTAURANT/EATING OUT | 1926 | 56.05 |
| WORK | 1001 | 29.13 |
| NONE OF THE ABOVE | 893 | 25.99 |
| SCHOOL | 160 | 4.66 |
| COLLEGE | 98 | 2.85 |
| DAYCARE | 8 | 0.23 |
n
= 3436
| Post-Exposure Time | Count | Percentage (%) |
|---|---|---|
| 4-6 HOURS | 1291 | 49.77 |
| 6-8 HOURS | 742 | 28.60 |
| 3 HOURS (180-239 MINUTES) | 681 | 26.25 |
| 1 TO 2 HOURS (61-120 MINUTES) | 569 | 21.94 |
| 6 TO 30 MINUTES | 472 | 18.20 |
| 2 HOURS (120-179 MINUTES) | 471 | 18.16 |
| 8 HOURS OR MORE | 425 | 16.38 |
| 31 TO 60 MINUTES | 403 | 15.54 |
| 0 TO 5 MINUTES | 328 | 12.64 |
| UNSURE | 159 | 6.13 |
n
= 3436
| Other Family Members Diagnosed with AGS | Count | Percentage (%) |
|---|---|---|
| NO | 2063 | 79.53 |
| NOT SURE | 137 | 5.28 |
| CHILD | 46 | 1.77 |
| SPOUSE | 44 | 1.70 |
| MOTHER | 39 | 1.50 |
| DAUGHTER | 28 | 1.08 |
| BROTHER | 27 | 1.04 |
| HUSBAND | 25 | 0.96 |
| SISTER | 22 | 0.85 |
| SON | 21 | 0.81 |
| FATHER | 16 | 0.62 |
| COUSIN | 12 | 0.46 |
| NEPHEW | 11 | 0.42 |
| SIBLING | 11 | 0.42 |
| AUNT | 10 | 0.39 |
| NIECE | 8 | 0.31 |
| BROTHER IN LAW | 7 | 0.27 |
| GRANDDAUGHTER | 6 | 0.23 |
| UNCLE | 6 | 0.23 |
| WIFE | 6 | 0.23 |
| 3 CHILDREN | 5 | 0.19 |
| MOM | 5 | 0.19 |
| COUSINS | 4 | 0.15 |
| FATHER IN LAW | 4 | 0.15 |
| MY HUSBAND | 4 | 0.15 |
| 2 DAUGHTERS | 3 | 0.12 |
| DAUGHTER IN LAW | 3 | 0.12 |
| GRANDSON | 3 | 0.12 |
| SISTER IN LAW | 3 | 0.12 |
| ADULT CHILD | 2 | 0.08 |
| DAD | 2 | 0.08 |
| GRANDCHILD | 2 | 0.08 |
| MOTHER AND SISTER IN LAW | 2 | 0.08 |
| MY NIECE | 2 | 0.08 |
| MY SISTER | 2 | 0.08 |
| NEICE | 2 | 0.08 |
| STEP FATHER | 2 | 0.08 |
| STEP SISTER | 2 | 0.08 |
| TWO DAUGHTERS | 2 | 0.08 |
| 2 CHILDREN | 1 | 0.04 |
| 3 COUSINS | 1 | 0.04 |
| 3RD COUSIN | 1 | 0.04 |
| A COUSIN | 1 | 0.04 |
| ADOPTED BROTHER (NOT GENETICALLY RELATED) | 1 | 0.04 |
| AND MY SISTER WHO IS 54 | 1 | 0.04 |
| AND NOW HE HAS NO PROBLEM. | 1 | 0.04 |
| AND POSSIBLY FATHER | 1 | 0.04 |
| AND SISTER | 1 | 0.04 |
| BUT MY LIVE-IN GIRLFRIENDS OLDEST SISTER WHO IS NOW 70 | 1 | 0.04 |
| BUT RECENTLY FOUND OUT SHE CAN EAT BEEF AGAIN. | 1 | 0.04 |
| CHILD (DAUGHTER) | 1 | 0.04 |
| DAD AND MOM BOTH GOT DIAGNOSED AFTER ME | 1 | 0.04 |
| DAUGHTER & SPOUSE | 1 | 0.04 |
| DAUGHTER-IN-LAW | 1 | 0.04 |
| DIFFERENT HOUSEHOLD | 1 | 0.04 |
| FIRST COUSIN | 1 | 0.04 |
| GRAND DAUGHTER | 1 | 0.04 |
| GRANDCHILDREN | 1 | 0.04 |
| GRANDMOTHER | 1 | 0.04 |
| GRANDSONS | 1 | 0.04 |
| GREAT AUNT | 1 | 0.04 |
| GREAT NEPHEW | 1 | 0.04 |
| GREAT UNCLE | 1 | 0.04 |
| HUSBAND AND TWO ADULT CHILDREN ARE AG POSTIVE | 1 | 0.04 |
| HUSBAND IS NOW BEING TESTED | 1 | 0.04 |
| I BELIEVE SPOUSE HAS BUT NOT TESTED | 1 | 0.04 |
| I HAVE A COUSIN WHO MIGHT HAVE IT | 1 | 0.04 |
| INLAWS | 1 | 0.04 |
| KIDS | 1 | 0.04 |
| MATERNAL COUSINS | 1 | 0.04 |
| MAYBE SON | 1 | 0.04 |
| ME | 1 | 0.04 |
| MOM WHO LIVES NEXT DOOR | 1 | 0.04 |
| MOTHER | 1 | 0.04 |
| MOTHER AND MAYBE OTHER FAMILY MEMBERS | 1 | 0.04 |
| MOTHER AND DAUGHTER | 1 | 0.04 |
| MOTHER AND MATERNAL GRANDFATHER | 1 | 0.04 |
| MOTHER AND SISTER | 1 | 0.04 |
| MOTHER AND SISTERS | 1 | 0.04 |
| MOTHER AND TWO SONS | 1 | 0.04 |
| MOTHER I CARE FOR | 1 | 0.04 |
| MOTHER IN LAW AND GRANDMOTHER IN LAW | 1 | 0.04 |
| MOTHER IN-LAW | 1 | 0.04 |
| MOTHER-IN-LAW | 1 | 0.04 |
| MY 12 YEAR OLD SON WAS DIAGNOSED RIGHT AFTER ME | 1 | 0.04 |
| MY 9 YEAR OLD DAUGHTER | 1 | 0.04 |
| MY BROTHER WHO IS 58 | 1 | 0.04 |
| MY CHILD | 1 | 0.04 |
| MY DAUGHTER HAD IT FOR 8 YEARS | 1 | 0.04 |
| MY HALF-SISTER ON MY FATHERS SIDE | 1 | 0.04 |
| MY HUSBAND’S UNCLE HAS ALSO BEEN DIAGNOSED. (NOT A BLOOD RELATIVE TO ME) | 1 | 0.04 |
| MY MOTHER AND MY NIECE | 1 | 0.04 |
| MY NEPHEW | 1 | 0.04 |
| MY OLDEST SON WAS DIAGNOSED DECEMBER 2019 | 1 | 0.04 |
| MY SON | 1 | 0.04 |
| MY SON HAD IT 8 YEARS | 1 | 0.04 |
| MY SPOUSE IS CURRENTLY BEING TESTED. WE HIGHLY SUSPECT HIS RESULTS WILL BE POSITIVE. | 1 | 0.04 |
| NEPHEW IN MONTANA | 1 | 0.04 |
| NIECE NIRVE GREAT NIECE NEPHEW GREAT NEPHEW | 1 | 0.04 |
| NIECE THAT DOES NOT LIVE WITH US | 1 | 0.04 |
| NINE CHILDREN | 1 | 0.04 |
| NOT FAMILY | 1 | 0.04 |
| NOT RELATED | 1 | 0.04 |
| OLDEST SON | 1 | 0.04 |
| PARENT | 1 | 0.04 |
| PATERNAL AUNT | 1 | 0.04 |
| RECENTLY DIAGNOSED. | 1 | 0.04 |
| SAME TOWN | 1 | 0.04 |
| SIBLING. BROTHER | 1 | 0.04 |
| SISTER 73 | 1 | 0.04 |
| SISTER AND NIECE | 1 | 0.04 |
| SISTER-IN-LAW | 1 | 0.04 |
| SISTERINLAW | 1 | 0.04 |
| SISTERS-IN-LAW | 1 | 0.04 |
| SON | 1 | 0.04 |
| SPOUSE AND CHILD | 1 | 0.04 |
| SPOUSE. DAUGHTER. | 1 | 0.04 |
| SPOUSE; HE HAS GI SYMPTOMS | 1 | 0.04 |
| STEP-BROTHER | 1 | 0.04 |
| STEPSON | 1 | 0.04 |
| TWO OF MY CHILDREN | 1 | 0.04 |
n
= 2594
| AGS Symptoms | Count | Percentage (%) |
|---|---|---|
| GASTROINTESTINAL | 2236 | 86.20 |
| SKIN | 2165 | 83.46 |
| RESPIRATORY | 1551 | 59.79 |
| CARDIOVASCULAR | 1072 | 41.33 |
| EMOTIONAL | 990 | 38.16 |
| MOTOR (MUSCLES) | 614 | 23.67 |
| NERVOUS SYSTEM (REFLEXES) | 603 | 23.25 |
| NOT SURE | 72 | 2.78 |
| 3 | 0.12 |
n
= 2591
| YEAR | AGS_SYMPTOMS | Count | Total | Percentage |
|---|---|---|---|---|
| 2019 | GASTROINTESTINAL | 396 | 2236 | 17.7 |
| 2020 | GASTROINTESTINAL | 378 | 2236 | 16.9 |
| 2021 | GASTROINTESTINAL | 180 | 2236 | 8.1 |
| 2022 | GASTROINTESTINAL | 507 | 2236 | 22.7 |
| 2023 | GASTROINTESTINAL | 517 | 2236 | 23.1 |
| 2024 | GASTROINTESTINAL | 258 | 2236 | 11.5 |
| 2019 | SKIN | 414 | 2165 | 19.1 |
| 2020 | SKIN | 410 | 2165 | 18.9 |
| 2021 | SKIN | 197 | 2165 | 9.1 |
| 2022 | SKIN | 493 | 2165 | 22.8 |
| 2023 | SKIN | 490 | 2165 | 22.6 |
| 2024 | SKIN | 161 | 2165 | 7.4 |
| 2019 | RESPIRATORY | 297 | 1551 | 19.1 |
| 2020 | RESPIRATORY | 310 | 1551 | 20.0 |
| 2021 | RESPIRATORY | 141 | 1551 | 9.1 |
| 2022 | RESPIRATORY | 331 | 1551 | 21.3 |
| 2023 | RESPIRATORY | 356 | 1551 | 23.0 |
| 2024 | RESPIRATORY | 116 | 1551 | 7.5 |
| 2019 | CARDIOVASCULAR | 185 | 1072 | 17.3 |
| 2020 | CARDIOVASCULAR | 202 | 1072 | 18.8 |
| 2021 | CARDIOVASCULAR | 94 | 1072 | 8.8 |
| 2022 | CARDIOVASCULAR | 234 | 1072 | 21.8 |
| 2023 | CARDIOVASCULAR | 268 | 1072 | 25.0 |
| 2024 | CARDIOVASCULAR | 89 | 1072 | 8.3 |
| 2019 | EMOTIONAL | 181 | 990 | 18.3 |
| 2020 | EMOTIONAL | 162 | 990 | 16.4 |
| 2021 | EMOTIONAL | 70 | 990 | 7.1 |
| 2022 | EMOTIONAL | 228 | 990 | 23.0 |
| 2023 | EMOTIONAL | 261 | 990 | 26.4 |
| 2024 | EMOTIONAL | 88 | 990 | 8.9 |
| 2019 | MOTOR (MUSCLES) | 107 | 614 | 17.4 |
| 2020 | MOTOR (MUSCLES) | 110 | 614 | 17.9 |
| 2021 | MOTOR (MUSCLES) | 48 | 614 | 7.8 |
| 2022 | MOTOR (MUSCLES) | 135 | 614 | 22.0 |
| 2023 | MOTOR (MUSCLES) | 158 | 614 | 25.7 |
| 2024 | MOTOR (MUSCLES) | 56 | 614 | 9.1 |
| 2019 | NERVOUS SYSTEM (REFLEXES) | 109 | 603 | 18.1 |
| 2020 | NERVOUS SYSTEM (REFLEXES) | 112 | 603 | 18.6 |
| 2021 | NERVOUS SYSTEM (REFLEXES) | 44 | 603 | 7.3 |
| 2022 | NERVOUS SYSTEM (REFLEXES) | 125 | 603 | 20.7 |
| 2023 | NERVOUS SYSTEM (REFLEXES) | 158 | 603 | 26.2 |
| 2024 | NERVOUS SYSTEM (REFLEXES) | 55 | 603 | 9.1 |
| 2019 | NOT SURE | 13 | 72 | 18.1 |
| 2020 | NOT SURE | 21 | 72 | 29.2 |
| 2021 | NOT SURE | 3 | 72 | 4.2 |
| 2022 | NOT SURE | 11 | 72 | 15.3 |
| 2023 | NOT SURE | 17 | 72 | 23.6 |
| 2024 | NOT SURE | 7 | 72 | 9.7 |
| Skin-Related Issues | Count | Percentage (%) |
|---|---|---|
| ITCHING | 2080 | 80.19 |
| HIVES (WELTS, URTICARIA) | 1840 | 70.93 |
| RASH (REDNESS OF SKIN) | 1492 | 57.52 |
| FLUSHING | 1486 | 57.29 |
| SWELLING (ANGIOEDEMA) | 1173 | 45.22 |
| HOT FLASH, HOT SKIN | 1170 | 45.10 |
| RED, ITCHY OR WATERY EYES | 1028 | 39.63 |
| NONE | 152 | 5.86 |
| UNSURE | 39 | 1.50 |
| 23 | 0.89 |
| Skin-Related Issues | Count | Percentage (%) |
|---|---|---|
| ITCHING | 2080 | 80.19 |
| HIVES (WELTS, URTICARIA) | 1840 | 70.93 |
| RASH (REDNESS OF SKIN) | 1492 | 57.52 |
| FLUSHING | 1486 | 57.29 |
| SWELLING (ANGIOEDEMA) | 1173 | 45.22 |
| HOT FLASH, HOT SKIN | 1170 | 45.10 |
| RED, ITCHY OR WATERY EYES | 1028 | 39.63 |
| NONE | 152 | 5.86 |
| UNSURE | 39 | 1.50 |
| Respiratory Issues | Count | Percentage (%) |
|---|---|---|
| NASAL CONGESTION/STUFFY OR RUNNY NOSE | 1318 | 50.81 |
| TROUBLE BREATHING (SHORTNESS OF BREATH) | 1203 | 46.38 |
| CHEST TIGHTENING | 1126 | 43.41 |
| COUGHING | 1126 | 43.41 |
| ANAPHYLAXIS | 905 | 34.89 |
| HOARSE VOICE | 877 | 33.81 |
| WHEEZING | 730 | 28.14 |
| SNEEZING | 646 | 24.90 |
| CHEST PAIN | 557 | 21.47 |
| NONE | 352 | 13.57 |
| UNSURE | 133 | 5.13 |
| 32 | 1.23 |
n
= 9005
| Gastrointestinal Issues | Count | Percentage (%) |
|---|---|---|
| DIARRHEA | 1891 | 72.90 |
| STOMACH PAIN/CRAMPS | 1868 | 72.01 |
| BLOATING | 1516 | 58.44 |
| NAUSEA | 1488 | 57.36 |
| ITCHY THROAT/EAR CANAL | 1152 | 44.41 |
| VOMITING | 916 | 35.31 |
| REFLUX | 896 | 34.54 |
| TONGUE SWELLING/THROAT TIGHTNESS | 880 | 33.92 |
| DIFFICULTY SWALLOWING | 706 | 27.22 |
| TINGLING MOUTH | 691 | 26.64 |
| CONSTIPATION | 648 | 24.98 |
| ODD TASTE IN MOUTH/METALLIC TASTE | 549 | 21.16 |
| BLOODY STOOLS | 167 | 6.44 |
| NONE | 103 | 3.97 |
| UNSURE | 51 | 1.97 |
| 19 | 0.73 |
n
= 13541
[1] 146
| Symptom | Count |
|---|---|
| GASTROINTESTINAL | 146 |
| Cardiovascular Issues | Count | Percentage (%) |
|---|---|---|
| LIGHTHEADEDNESS/DIZZINESS | 1338 | 51.58 |
| RAPID HEARTBEAT (TACHYCARDIA) | 1022 | 39.40 |
| LOW BLOOD PRESSURE | 738 | 28.45 |
| IRREGULAR HEART RATE | 712 | 27.45 |
| CHEST PAIN | 501 | 19.31 |
| NONE | 481 | 18.54 |
| A WEAK PULSE | 280 | 10.79 |
| UNSURE | 279 | 10.76 |
| SLOW HEARTBEAT (BRADYCARDIA) | 167 | 6.44 |
| TURNING BLUE | 60 | 2.31 |
| 45 | 1.73 | |
| CARDIAC ARREST | 24 | 0.93 |
n
= 5647
| Emotional/Behavioral Issues | Count | Percentage (%) |
|---|---|---|
| ANXIETY | 1696 | 65.38 |
| FATIGUE | 1476 | 56.90 |
| SLEEP DISTURBANCES | 1130 | 43.56 |
| HEADACHE/MIGRAINES | 1065 | 41.06 |
| WITHDRAWAL FROM SOCIAL AND RECREATIONAL ACTIVITIES | 998 | 38.47 |
| IRRITABILITY | 986 | 38.01 |
| FEELING OF “IMPENDING DOOM” | 872 | 33.62 |
| MEMORY RECALL | 833 | 32.11 |
| DEPRESSION | 823 | 31.73 |
| PANIC | 793 | 30.57 |
| CONFUSION | 715 | 27.56 |
| NONE | 229 | 8.83 |
| UNSURE | 112 | 4.32 |
| 18 | 0.69 |
n
= 11746
| Nervous System Issues | Count | Percentage (%) |
|---|---|---|
| ABNORMAL SWEATING | 768 | 29.61 |
| DRY SKIN | 599 | 23.09 |
| NONE | 560 | 21.59 |
| DEHYDRATION | 557 | 21.47 |
| WEIGHT GAIN | 524 | 20.20 |
| WEIGHT LOSS | 436 | 16.81 |
| FAINTING OR LOSS OF CONSCIOUSNESS | 430 | 16.58 |
| UNSURE | 396 | 15.27 |
| URINARY DYSFUNCTION | 265 | 10.22 |
| SEXUAL DYSFUNCTION | 213 | 8.21 |
| UTERINE CONTRACTIONS | 103 | 3.97 |
| 89 | 3.43 |
n
= 4940
| Motor Issues | Count | Percentage (%) |
|---|---|---|
| NONE | 916 | 35.31 |
| MUSCLE CRAMPING | 889 | 34.27 |
| LEG WEAKNESS | 599 | 23.09 |
| ARM WEAKNESS | 529 | 20.39 |
| NOT SURE | 426 | 16.42 |
| MUSCLE WASTING | 177 | 6.82 |
| CLAWING OF TOES | 155 | 5.98 |
| 128 | 4.93 |
n
= 3819
| Comorbid Diagnosis | Count | Percentage (%) |
|---|---|---|
| ALLERGIC RHINITIS (HAY FEVER) | 927 | 35.74 |
| VITAMIN D DEFICIENCY | 923 | 35.58 |
| HEARTBURN (ACID REFLUX) | 896 | 34.54 |
| DRUG ALLERGY | 794 | 30.61 |
| HIGH BLOOD PRESSURE (HYPERTENSION) | 768 | 29.61 |
| ANAPHYLAXIS | 687 | 26.48 |
| ASTHMA | 631 | 24.33 |
| MIGRAINE HEADACHES | 599 | 23.09 |
| IRRITABLE BOWEL SYNDROME | 513 | 19.78 |
| THYROID DISEASE | 393 | 15.15 |
| OSTEOARTHRITIS | 378 | 14.57 |
| BEE STING ALLERGY | 353 | 13.61 |
| HYPERTENSION | 339 | 13.07 |
| LACTOSE INTOLERANCE | 328 | 12.64 |
| CONTACT DERMATITIS | 312 | 12.03 |
| MENTAL HEALTH DISORDER | 310 | 11.95 |
| ATOPIC DERMATITIS (ECZEMA) | 309 | 11.91 |
| GLUTEN SENSITIVITY | 280 | 10.79 |
| LATEX ALLERGY | 272 | 10.49 |
| TYPE 2 DIABETES | 227 | 8.75 |
| NONE | 199 | 7.67 |
| ATTENTION-DEFICIT/HYPERACTIVITY DISORDER (ADHD) | 196 | 7.56 |
| CANCER | 188 | 7.25 |
| MAST CELL DISEASE | 185 | 7.13 |
| ARRHYTHMIAS | 172 | 6.63 |
| RHEUMATOID ARTHRITIS | 118 | 4.55 |
| HEART DISEASE | 105 | 4.05 |
| ORAL ALLERGY SYNDROME (OAS)/POLLEN-FOOD SYNDROME | 92 | 3.55 |
| CONNECTIVE TISSUE DISORDER | 86 | 3.32 |
| HEART DEFECTS | 74 | 2.85 |
| INFLAMMATORY BOWEL DISEASE (CROHN’S DISEASE/ULCERATIVE COLITIS) | 57 | 2.20 |
| CELIAC DISEASE | 47 | 1.81 |
| STROKE | 47 | 1.81 |
| EOSINOPHILIC ESOPHAGITIS | 36 | 1.39 |
| UNSURE | 35 | 1.35 |
| HISTAMINE TOXICITY (SCOMBROID POISONING) | 23 | 0.89 |
| 16 | 0.62 | |
| HYPER-IGE SYNDROME (HIE) | 15 | 0.58 |
| AUTISM | 12 | 0.46 |
| FOOD PROTEIN-INDUCED ENTEROCOLITIS SYNDROME (FPIES) | 12 | 0.46 |
| TYPE 1 DIABETES | 11 | 0.42 |
n
= 11965
| Outgrown or Tolerant to Mammalian Ingredients | Count | Percentage (%) |
|---|---|---|
| NO | 1865 | 71.90 |
| UNSURE | 546 | 21.05 |
| YES | 183 | 7.05 |
n
= 2594
| Question | N Total | N Answered | Response Rate |
|---|---|---|---|
| Please provide any additional input, comments, opinions, or suggestions below. Please feel free to share advice or feedback for healthcare providers, other AGS patients, or other affected individuals. | 3437 | 1666 | 48.5% |
| Besides avoidance of mammalian ingredients, are there other therapies or interventions you have discovered that help reduce the severity and frequency of Alpha-gal reactions or symptoms? Please Explain. | 3437 | 2199 | 64.0% |
| Ethnicity: | 3437 | 2248 | 65.4% |
| Have you ever been diagnosed with any of the following tick-borne conditions? Please check all that apply. | 3437 | 2257 | 65.7% |
| Education: | 3437 | 2257 | 65.7% |
| Race (Select all that apply): | 3437 | 2269 | 66.0% |
| Household Income: | 3437 | 2272 | 66.1% |
| PREVENTION_METHOD | 3437 | 2273 | 66.1% |
| Zip Code: | 3437 | 2291 | 66.7% |
| When was your MOST RECENT AGS blood test performed and what was your Alpha-gal IgE value? | 3437 | 2294 | 66.7% |
| Gender: | 3437 | 2312 | 67.3% |
| Age Range: | 3437 | 2317 | 67.4% |
| This concludes our survey. THANK YOU for your participation. Do you want to be contacted by TBC United with information about future clinical trials or research studies?: | 3437 | 2323 | 67.6% |
| MENTAL_HEALTH_CONCERNS | 3437 | 2344 | 68.2% |
| What, if any, financial impacts (positive or negative) have you experienced due to Alpha-gal Syndrome? | 3437 | 2348 | 68.3% |
| What type of doctor or healthcare provider first made the Alpha-gal syndrome diagnosis? | 3437 | 2363 | 68.8% |
| What, if any, social impacts (positive or negative) have you experienced due to Alpha-gal Syndrome (e.g. ability to go out, spend time with family and friends, etc)? | 3437 | 2402 | 69.9% |
| Has the participant ever been diagnosed by a doctor as allergic to any of the following foods or food groups? (Check all that apply.) | 3437 | 2467 | 71.8% |
| Choose the MOTOR (muscle) symptoms that you experience after exposure to mammalian ingredients. (Select all that apply.) | 3437 | 2467 | 71.8% |
| Choose the NERVOUS SYSTEM (reflexes) symptoms that you experience after exposure to mammalian ingredients. (Select all that apply.) | 3437 | 2506 | 72.9% |
| Do you currently use products that have been genetically modified? | 3437 | 2510 | 73.0% |
| Indicate your willingness to consume a food product such as steak, bacon, or lamb that is a product of animal biotechnology. | 3437 | 2510 | 73.0% |
| Indicate your willingness to use OVER-THE-COUNTER MEDICATIONS with mammal ingredients that have had the alpha-gal carbohydrate removed and verified to be Alpha-gal free. | 3437 | 2510 | 73.0% |
| Indicate your willingness to use PRESCRIPTION MEDICATIONS with mammal ingredients that have had the alpha-gal carbohydrate removed and verified to be Alpha-gal free. | 3437 | 2510 | 73.0% |
| Indicate your willingness to use VACCINATIONS with mammal ingredients that have had the alpha-gal carbohydrate removed and verified to be Alpha-gal free. | 3437 | 2510 | 73.0% |
| Indicate your willingness to use FOOD PRODUCTS such as steak, bacon, or lamb that have had the alpha-gal carbohydrate removed and verified to be Alpha-gal free. | 3437 | 2510 | 73.0% |
| Indicate your willingness to use PERSONAL CARE PRODUCTS such as shampoo or cosmetics with mammal ingredients that have had the alpha-gal carbohydrate removed and verified to be Alpha-gal free. | 3437 | 2510 | 73.0% |
| Indicate your willingness to use HOUSEHOLD PRODUCTS such as cleaning products or laundry detergent with mammal ingredients that have had the alpha-gal carbohydrate removed and verified to be Alpha-gal free. | 3437 | 2510 | 73.0% |
| ACCESS_INFORMATION | 3437 | 2536 | 73.8% |
| When was your FIRST AGS blood test performed and what was your Alpha-gal IgE value? | 3437 | 2543 | 74.0% |
| Where have you had exposures that caused reactions to occur? Check all that apply. | 3437 | 2544 | 74.0% |
| Choose the CARDIOVASCULAR (heart) symptoms you experience from a reaction to mammalian ingredients. (Select all that apply.) | 3437 | 2550 | 74.2% |
| At what age did you first begin experiencing allergic reactions (e.g. eczema, hives, itching) to mammalian ingredients? | 3437 | 2554 | 74.3% |
| What mammalian ingredients/items have you reacted to? Check all that apply. | 3437 | 2559 | 74.5% |
| Choose the RESPIRATORY (lungs/breathing) symptoms you experience from a reaction to mammalian ingredients (Select all that apply.) | 3437 | 2563 | 74.6% |
| How easy is it to identify Alpha-gal free vaccines? | 3437 | 2567 | 74.7% |
| How easy is it to identify Alpha-gal free household items? Examples include cleaning products, laundry detergent, and dryer sheets. | 3437 | 2568 | 74.7% |
| How easy is it to identify Alpha-gal free personal care products? Examples include shampoo, cosmetics, and soap. | 3437 | 2569 | 74.7% |
| How easy is it to identify Alpha-gal free over-the-counter medications? | 3437 | 2570 | 74.8% |
| How easy is it to identify Alpha-gal free prescription medications? | 3437 | 2570 | 74.8% |
| Choose the SKIN symptoms you experience from a reaction to mammalian ingredients. (Select all that apply.) | 3437 | 2572 | 74.8% |
| Would you use an Alpha-gal free valve replacement that was from a pig or other mammal that has been genetically modified? | 3437 | 2572 | 74.8% |
| Choose the GASTROINTESTINAL (digestive tract) symptoms you experience from a reaction to mammalian ingredients. (Select all that apply.) | 3437 | 2576 | 74.9% |
| Choose the EMOTIONAL/BEHAVIORAL symptoms you experience due to the Alpha-gal Syndrome diagnosis (Select all that apply.) | 3437 | 2577 | 75.0% |
| COMORBID_DIAGNOSIS | 3437 | 2579 | 75.0% |
| How many reactions did you experience prior to diagnosis? | 3437 | 2581 | 75.1% |
| How easy is it to identify Alpha-gal free food products? (Likeart scale 1-10) | 3437 | 2586 | 75.2% |
| If you needed a heart valve replacement and it were available, would you ask your healthcare provider to use an Alpha-gal free heart valve? | 3437 | 2588 | 75.3% |
| Would you eat Alpha-gal free pork, beef, or lamb? | 3437 | 2589 | 75.3% |
| What type of symptoms do you have? (Select all that apply.) | 3437 | 2592 | 75.4% |
| Do you remember being bitten by a tick prior to symptoms of Alpha-gal Syndrome? | 3437 | 2595 | 75.5% |
| At what age were you diagnosed with Alpha-gal Syndrome? | 3437 | 2595 | 75.5% |
| Before you developed Alpha-gal Syndrome, what was your primary dietary preference? Please select the best option. | 3437 | 2595 | 75.5% |
| Since your Alpha-gal Syndrome diagnosis, how many reactions do you have per year? | 3437 | 2595 | 75.5% |
| Which of the following medical interventions have you experienced because of Alpha-gal Syndrome? | 3437 | 2595 | 75.5% |
| How soon after exposure to mammalian ingredients do your reactions occur? Check all that apply. | 3437 | 2595 | 75.5% |
| Do you have other family members diagnosed with AGS? | 3437 | 2595 | 75.5% |
| OUTGROWN_OR_TOLERANT_TO_MAMMALIAN_INGREDIENTS | 3437 | 2595 | 75.5% |
| You are invited to participate | 3437 | 3418 | 99.4% |
| Respondent ID | 3437 | 3437 | 100.0% |
| Collector ID | 3437 | 3437 | 100.0% |
| Start Date | 3437 | 3437 | 100.0% |
| End Date | 3437 | 3437 | 100.0% |
| IP Address | 3437 | 3437 | 100.0% |
| Have you been diagnosed with Alpha-gal Syndrome? | 3437 | 3437 | 100.0% |
| Question | N Total | N Answered | N Non-response | N Opt-out | Response Rate | Non-response Rate | Opt-out Rate | High Non-response? | High Opt-out? |
|---|---|---|---|---|---|---|---|---|---|
| Please provide any additional input, comments, opinions, or suggestions below. Please feel free to share advice or feedback for healthcare providers, other AGS patients, or other affected individuals. | 3437 | 1666 | 1771 | 433 | 48.5% | 51.5% | 12.6% | TRUE | TRUE |
| Besides avoidance of mammalian ingredients, are there other therapies or interventions you have discovered that help reduce the severity and frequency of Alpha-gal reactions or symptoms? Please Explain. | 3437 | 2199 | 1238 | 338 | 64.0% | 36.0% | 9.8% | TRUE | TRUE |
| Ethnicity: | 3437 | 2248 | 1189 | 0 | 65.4% | 34.6% | 0.0% | TRUE | FALSE |
| Education: | 3437 | 2257 | 1180 | 239 | 65.7% | 34.3% | 7.0% | TRUE | TRUE |
| Have you ever been diagnosed with any of the following tick-borne conditions? Please check all that apply. | 3437 | 2257 | 1180 | 5 | 65.7% | 34.3% | 0.1% | TRUE | FALSE |
| Race (Select all that apply): | 3437 | 2269 | 1168 | 55 | 66.0% | 34.0% | 1.6% | TRUE | FALSE |
| Household Income: | 3437 | 2272 | 1165 | 88 | 66.1% | 33.9% | 2.6% | TRUE | FALSE |
| PREVENTION_METHOD | 3437 | 2273 | 1164 | 1357 | 66.1% | 33.9% | 39.5% | TRUE | TRUE |
| Zip Code: | 3437 | 2291 | 1146 | 0 | 66.7% | 33.3% | 0.0% | TRUE | FALSE |
| When was your MOST RECENT AGS blood test performed and what was your Alpha-gal IgE value? | 3437 | 2294 | 1143 | 43 | 66.7% | 33.3% | 1.3% | TRUE | FALSE |
| Gender: | 3437 | 2312 | 1125 | 0 | 67.3% | 32.7% | 0.0% | TRUE | FALSE |
| Age Range: | 3437 | 2317 | 1120 | 0 | 67.4% | 32.6% | 0.0% | TRUE | FALSE |
| This concludes our survey. THANK YOU for your participation. Do you want to be contacted by TBC United with information about future clinical trials or research studies?: | 3437 | 2323 | 1114 | 82 | 67.6% | 32.4% | 2.4% | TRUE | FALSE |
| MENTAL_HEALTH_CONCERNS | 3437 | 2344 | 1093 | 0 | 68.2% | 31.8% | 0.0% | TRUE | FALSE |
| What, if any, financial impacts (positive or negative) have you experienced due to Alpha-gal Syndrome? | 3437 | 2348 | 1089 | 343 | 68.3% | 31.7% | 10.0% | TRUE | TRUE |
| What type of doctor or healthcare provider first made the Alpha-gal syndrome diagnosis? | 3437 | 2363 | 1074 | 0 | 68.8% | 31.2% | 0.0% | TRUE | FALSE |
| What, if any, social impacts (positive or negative) have you experienced due to Alpha-gal Syndrome (e.g. ability to go out, spend time with family and friends, etc)? | 3437 | 2402 | 1035 | 278 | 69.9% | 30.1% | 8.1% | TRUE | TRUE |
| Has the participant ever been diagnosed by a doctor as allergic to any of the following foods or food groups? (Check all that apply.) | 3437 | 2467 | 970 | 264 | 71.8% | 28.2% | 7.7% | TRUE | TRUE |
| Choose the MOTOR (muscle) symptoms that you experience after exposure to mammalian ingredients. (Select all that apply.) | 3437 | 2467 | 970 | 0 | 71.8% | 28.2% | 0.0% | TRUE | FALSE |
| Choose the NERVOUS SYSTEM (reflexes) symptoms that you experience after exposure to mammalian ingredients. (Select all that apply.) | 3437 | 2506 | 931 | 265 | 72.9% | 27.1% | 7.7% | TRUE | TRUE |
| Do you currently use products that have been genetically modified? | 3437 | 2510 | 927 | 0 | 73.0% | 27.0% | 0.0% | TRUE | FALSE |
| Indicate your willingness to consume a food product such as steak, bacon, or lamb that is a product of animal biotechnology. | 3437 | 2510 | 927 | 0 | 73.0% | 27.0% | 0.0% | TRUE | FALSE |
| Indicate your willingness to use OVER-THE-COUNTER MEDICATIONS with mammal ingredients that have had the alpha-gal carbohydrate removed and verified to be Alpha-gal free. | 3437 | 2510 | 927 | 0 | 73.0% | 27.0% | 0.0% | TRUE | FALSE |
| Indicate your willingness to use PRESCRIPTION MEDICATIONS with mammal ingredients that have had the alpha-gal carbohydrate removed and verified to be Alpha-gal free. | 3437 | 2510 | 927 | 0 | 73.0% | 27.0% | 0.0% | TRUE | FALSE |
| Indicate your willingness to use VACCINATIONS with mammal ingredients that have had the alpha-gal carbohydrate removed and verified to be Alpha-gal free. | 3437 | 2510 | 927 | 0 | 73.0% | 27.0% | 0.0% | TRUE | FALSE |
| Indicate your willingness to use FOOD PRODUCTS such as steak, bacon, or lamb that have had the alpha-gal carbohydrate removed and verified to be Alpha-gal free. | 3437 | 2510 | 927 | 0 | 73.0% | 27.0% | 0.0% | TRUE | FALSE |
| Indicate your willingness to use PERSONAL CARE PRODUCTS such as shampoo or cosmetics with mammal ingredients that have had the alpha-gal carbohydrate removed and verified to be Alpha-gal free. | 3437 | 2510 | 927 | 0 | 73.0% | 27.0% | 0.0% | TRUE | FALSE |
| Indicate your willingness to use HOUSEHOLD PRODUCTS such as cleaning products or laundry detergent with mammal ingredients that have had the alpha-gal carbohydrate removed and verified to be Alpha-gal free. | 3437 | 2510 | 927 | 0 | 73.0% | 27.0% | 0.0% | TRUE | FALSE |
| ACCESS_INFORMATION | 3437 | 2536 | 901 | 0 | 73.8% | 26.2% | 0.0% | TRUE | FALSE |
| When was your FIRST AGS blood test performed and what was your Alpha-gal IgE value? | 3437 | 2543 | 894 | 11 | 74.0% | 26.0% | 0.3% | TRUE | FALSE |
| Where have you had exposures that caused reactions to occur? Check all that apply. | 3437 | 2544 | 893 | 0 | 74.0% | 26.0% | 0.0% | TRUE | FALSE |
| Choose the CARDIOVASCULAR (heart) symptoms you experience from a reaction to mammalian ingredients. (Select all that apply.) | 3437 | 2550 | 887 | 0 | 74.2% | 25.8% | 0.0% | TRUE | FALSE |
| At what age did you first begin experiencing allergic reactions (e.g. eczema, hives, itching) to mammalian ingredients? | 3437 | 2554 | 883 | 0 | 74.3% | 25.7% | 0.0% | TRUE | FALSE |
| What mammalian ingredients/items have you reacted to? Check all that apply. | 3437 | 2559 | 878 | 1200 | 74.5% | 25.5% | 34.9% | TRUE | TRUE |
| Choose the RESPIRATORY (lungs/breathing) symptoms you experience from a reaction to mammalian ingredients (Select all that apply.) | 3437 | 2563 | 874 | 1726 | 74.6% | 25.4% | 50.2% | TRUE | TRUE |
| How easy is it to identify Alpha-gal free vaccines? | 3437 | 2567 | 870 | 0 | 74.7% | 25.3% | 0.0% | TRUE | FALSE |
| How easy is it to identify Alpha-gal free household items? Examples include cleaning products, laundry detergent, and dryer sheets. | 3437 | 2568 | 869 | 0 | 74.7% | 25.3% | 0.0% | TRUE | FALSE |
| How easy is it to identify Alpha-gal free personal care products? Examples include shampoo, cosmetics, and soap. | 3437 | 2569 | 868 | 0 | 74.7% | 25.3% | 0.0% | TRUE | FALSE |
| How easy is it to identify Alpha-gal free over-the-counter medications? | 3437 | 2570 | 867 | 0 | 74.8% | 25.2% | 0.0% | TRUE | FALSE |
| How easy is it to identify Alpha-gal free prescription medications? | 3437 | 2570 | 867 | 0 | 74.8% | 25.2% | 0.0% | TRUE | FALSE |
| Choose the SKIN symptoms you experience from a reaction to mammalian ingredients. (Select all that apply.) | 3437 | 2572 | 865 | 0 | 74.8% | 25.2% | 0.0% | TRUE | FALSE |
| Would you use an Alpha-gal free valve replacement that was from a pig or other mammal that has been genetically modified? | 3437 | 2572 | 865 | 0 | 74.8% | 25.2% | 0.0% | TRUE | FALSE |
| Choose the GASTROINTESTINAL (digestive tract) symptoms you experience from a reaction to mammalian ingredients. (Select all that apply.) | 3437 | 2576 | 861 | 1845 | 74.9% | 25.1% | 53.7% | TRUE | TRUE |
| Choose the EMOTIONAL/BEHAVIORAL symptoms you experience due to the Alpha-gal Syndrome diagnosis (Select all that apply.) | 3437 | 2577 | 860 | 998 | 75.0% | 25.0% | 29.0% | TRUE | TRUE |
| COMORBID_DIAGNOSIS | 3437 | 2579 | 858 | 688 | 75.0% | 25.0% | 20.0% | TRUE | TRUE |
| How many reactions did you experience prior to diagnosis? | 3437 | 2581 | 856 | 0 | 75.1% | 24.9% | 0.0% | TRUE | FALSE |
| How easy is it to identify Alpha-gal free food products? (Likeart scale 1-10) | 3437 | 2586 | 851 | 0 | 75.2% | 24.8% | 0.0% | TRUE | FALSE |
| If you needed a heart valve replacement and it were available, would you ask your healthcare provider to use an Alpha-gal free heart valve? | 3437 | 2588 | 849 | 0 | 75.3% | 24.7% | 0.0% | TRUE | FALSE |
| Would you eat Alpha-gal free pork, beef, or lamb? | 3437 | 2589 | 848 | 0 | 75.3% | 24.7% | 0.0% | TRUE | FALSE |
| What type of symptoms do you have? (Select all that apply.) | 3437 | 2592 | 845 | 2310 | 75.4% | 24.6% | 67.2% | TRUE | TRUE |
| Do you have other family members diagnosed with AGS? | 3437 | 2595 | 842 | 7 | 75.5% | 24.5% | 0.2% | TRUE | FALSE |
| Do you remember being bitten by a tick prior to symptoms of Alpha-gal Syndrome? | 3437 | 2595 | 842 | 0 | 75.5% | 24.5% | 0.0% | TRUE | FALSE |
| At what age were you diagnosed with Alpha-gal Syndrome? | 3437 | 2595 | 842 | 0 | 75.5% | 24.5% | 0.0% | TRUE | FALSE |
| Before you developed Alpha-gal Syndrome, what was your primary dietary preference? Please select the best option. | 3437 | 2595 | 842 | 0 | 75.5% | 24.5% | 0.0% | TRUE | FALSE |
| Since your Alpha-gal Syndrome diagnosis, how many reactions do you have per year? | 3437 | 2595 | 842 | 0 | 75.5% | 24.5% | 0.0% | TRUE | FALSE |
| Which of the following medical interventions have you experienced because of Alpha-gal Syndrome? | 3437 | 2595 | 842 | 0 | 75.5% | 24.5% | 0.0% | TRUE | FALSE |
| How soon after exposure to mammalian ingredients do your reactions occur? Check all that apply. | 3437 | 2595 | 842 | 0 | 75.5% | 24.5% | 0.0% | TRUE | FALSE |
| OUTGROWN_OR_TOLERANT_TO_MAMMALIAN_INGREDIENTS | 3437 | 2595 | 842 | 0 | 75.5% | 24.5% | 0.0% | TRUE | FALSE |
Count = number of those respondents who selected that specific category from AGS_SYMPTOMS
YearN = number of respondents in that year who gave a nonblank answer to AGS_SYMPTOMS
Total = Count of respondents across all years who selected that specific symptom category
| YEAR | AGS_SYMPTOMS | Count | YearN | Percentage | Total |
|---|---|---|---|---|---|
| 2019 | GASTROINTESTINAL | 396 | 467 | 84.8 | 2236 |
| 2020 | GASTROINTESTINAL | 378 | 470 | 80.4 | 2236 |
| 2021 | GASTROINTESTINAL | 180 | 221 | 81.4 | 2236 |
| 2022 | GASTROINTESTINAL | 507 | 584 | 86.8 | 2236 |
| 2023 | GASTROINTESTINAL | 517 | 580 | 89.1 | 2236 |
| 2024 | GASTROINTESTINAL | 258 | 269 | 95.9 | 2236 |
| 2019 | SKIN | 414 | 467 | 88.7 | 2165 |
| 2020 | SKIN | 410 | 470 | 87.2 | 2165 |
| 2021 | SKIN | 197 | 221 | 89.1 | 2165 |
| 2022 | SKIN | 493 | 584 | 84.4 | 2165 |
| 2023 | SKIN | 490 | 580 | 84.5 | 2165 |
| 2024 | SKIN | 161 | 269 | 59.9 | 2165 |
| 2019 | RESPIRATORY | 297 | 467 | 63.6 | 1551 |
| 2020 | RESPIRATORY | 310 | 470 | 66.0 | 1551 |
| 2021 | RESPIRATORY | 141 | 221 | 63.8 | 1551 |
| 2022 | RESPIRATORY | 331 | 584 | 56.7 | 1551 |
| 2023 | RESPIRATORY | 356 | 580 | 61.4 | 1551 |
| 2024 | RESPIRATORY | 116 | 269 | 43.1 | 1551 |
| 2019 | CARDIOVASCULAR | 185 | 467 | 39.6 | 1072 |
| 2020 | CARDIOVASCULAR | 202 | 470 | 43.0 | 1072 |
| 2021 | CARDIOVASCULAR | 94 | 221 | 42.5 | 1072 |
| 2022 | CARDIOVASCULAR | 234 | 584 | 40.1 | 1072 |
| 2023 | CARDIOVASCULAR | 268 | 580 | 46.2 | 1072 |
| 2024 | CARDIOVASCULAR | 89 | 269 | 33.1 | 1072 |
| 2019 | EMOTIONAL | 181 | 467 | 38.8 | 990 |
| 2020 | EMOTIONAL | 162 | 470 | 34.5 | 990 |
| 2021 | EMOTIONAL | 70 | 221 | 31.7 | 990 |
| 2022 | EMOTIONAL | 228 | 584 | 39.0 | 990 |
| 2023 | EMOTIONAL | 261 | 580 | 45.0 | 990 |
| 2024 | EMOTIONAL | 88 | 269 | 32.7 | 990 |
| 2019 | MOTOR (MUSCLES) | 107 | 467 | 22.9 | 614 |
| 2020 | MOTOR (MUSCLES) | 110 | 470 | 23.4 | 614 |
| 2021 | MOTOR (MUSCLES) | 48 | 221 | 21.7 | 614 |
| 2022 | MOTOR (MUSCLES) | 135 | 584 | 23.1 | 614 |
| 2023 | MOTOR (MUSCLES) | 158 | 580 | 27.2 | 614 |
| 2024 | MOTOR (MUSCLES) | 56 | 269 | 20.8 | 614 |
| 2019 | NERVOUS SYSTEM (REFLEXES) | 109 | 467 | 23.3 | 603 |
| 2020 | NERVOUS SYSTEM (REFLEXES) | 112 | 470 | 23.8 | 603 |
| 2021 | NERVOUS SYSTEM (REFLEXES) | 44 | 221 | 19.9 | 603 |
| 2022 | NERVOUS SYSTEM (REFLEXES) | 125 | 584 | 21.4 | 603 |
| 2023 | NERVOUS SYSTEM (REFLEXES) | 158 | 580 | 27.2 | 603 |
| 2024 | NERVOUS SYSTEM (REFLEXES) | 55 | 269 | 20.4 | 603 |
| 2019 | NOT SURE | 13 | 467 | 2.8 | 72 |
| 2020 | NOT SURE | 21 | 470 | 4.5 | 72 |
| 2021 | NOT SURE | 3 | 221 | 1.4 | 72 |
| 2022 | NOT SURE | 11 | 584 | 1.9 | 72 |
| 2023 | NOT SURE | 17 | 580 | 2.9 | 72 |
| 2024 | NOT SURE | 7 | 269 | 2.6 | 72 |
YearN = count of those answered records within each year (Denomenator)
Count= respondent answered yes, (numerator)
| YEAR | AGS_SYMPTOMS | Count | YearN | Percentage |
|---|---|---|---|---|
| 2019 | GASTROINTESTINAL | 396 | 467 | 84.8 |
| 2020 | GASTROINTESTINAL | 378 | 470 | 80.4 |
| 2021 | GASTROINTESTINAL | 180 | 221 | 81.4 |
| 2022 | GASTROINTESTINAL | 507 | 584 | 86.8 |
| 2023 | GASTROINTESTINAL | 517 | 580 | 89.1 |
| 2024 | GASTROINTESTINAL | 258 | 269 | 95.9 |
| 2019 | SKIN | 414 | 467 | 88.7 |
| 2020 | SKIN | 410 | 470 | 87.2 |
| 2021 | SKIN | 197 | 221 | 89.1 |
| 2022 | SKIN | 493 | 584 | 84.4 |
| 2023 | SKIN | 490 | 580 | 84.5 |
| 2024 | SKIN | 161 | 269 | 59.9 |
| 2019 | RESPIRATORY | 297 | 467 | 63.6 |
| 2020 | RESPIRATORY | 310 | 470 | 66.0 |
| 2021 | RESPIRATORY | 141 | 221 | 63.8 |
| 2022 | RESPIRATORY | 331 | 584 | 56.7 |
| 2023 | RESPIRATORY | 356 | 580 | 61.4 |
| 2024 | RESPIRATORY | 116 | 269 | 43.1 |
| 2019 | CARDIOVASCULAR | 185 | 467 | 39.6 |
| 2020 | CARDIOVASCULAR | 202 | 470 | 43.0 |
| 2021 | CARDIOVASCULAR | 94 | 221 | 42.5 |
| 2022 | CARDIOVASCULAR | 234 | 584 | 40.1 |
| 2023 | CARDIOVASCULAR | 268 | 580 | 46.2 |
| 2024 | CARDIOVASCULAR | 89 | 269 | 33.1 |
| 2019 | EMOTIONAL | 181 | 467 | 38.8 |
| 2020 | EMOTIONAL | 162 | 470 | 34.5 |
| 2021 | EMOTIONAL | 70 | 221 | 31.7 |
| 2022 | EMOTIONAL | 228 | 584 | 39.0 |
| 2023 | EMOTIONAL | 261 | 580 | 45.0 |
| 2024 | EMOTIONAL | 88 | 269 | 32.7 |
| 2019 | MOTOR (MUSCLES) | 107 | 467 | 22.9 |
| 2020 | MOTOR (MUSCLES) | 110 | 470 | 23.4 |
| 2021 | MOTOR (MUSCLES) | 48 | 221 | 21.7 |
| 2022 | MOTOR (MUSCLES) | 135 | 584 | 23.1 |
| 2023 | MOTOR (MUSCLES) | 158 | 580 | 27.2 |
| 2024 | MOTOR (MUSCLES) | 56 | 269 | 20.8 |
| 2019 | NERVOUS SYSTEM (REFLEXES) | 109 | 467 | 23.3 |
| 2020 | NERVOUS SYSTEM (REFLEXES) | 112 | 470 | 23.8 |
| 2021 | NERVOUS SYSTEM (REFLEXES) | 44 | 221 | 19.9 |
| 2022 | NERVOUS SYSTEM (REFLEXES) | 125 | 584 | 21.4 |
| 2023 | NERVOUS SYSTEM (REFLEXES) | 158 | 580 | 27.2 |
| 2024 | NERVOUS SYSTEM (REFLEXES) | 55 | 269 | 20.4 |
| 2019 | NOT SURE | 13 | 467 | 2.8 |
| 2020 | NOT SURE | 21 | 470 | 4.5 |
| 2021 | NOT SURE | 3 | 221 | 1.4 |
| 2022 | NOT SURE | 11 | 584 | 1.9 |
| 2023 | NOT SURE | 17 | 580 | 2.9 |
| 2024 | NOT SURE | 7 | 269 | 2.6 |
This code analyzes whether the major AGS symptom categories changed by year.
It uses the AGS_SYMPTOMS field, which contains the main
symptom categories each respondent selected. The code first identifies
respondents who answered that symptom question, then splits the
multi-select responses into individual categories such as Skin,
Gastrointestinal, and Respiratory.
For each category, the code creates a yes/no flag for whether that respondent selected it and runs a logistic regression by year. This tests whether the likelihood of selecting each symptom category was significantly different across survey years.
| Symptom | N | Events | LR_Stat | DF | P_Value | Converged | Note | P_Adjusted | Significant |
|---|---|---|---|---|---|---|---|---|---|
| SKIN | 2591 | 2165 | 106.277754 | 5 | 0.0000000 | TRUE | NA | 0.0000000 | TRUE |
| GASTROINTESTINAL | 2591 | 2236 | 49.482478 | 5 | 0.0000000 | TRUE | NA | 0.0000000 | TRUE |
| RESPIRATORY | 2591 | 1551 | 45.170971 | 5 | 0.0000000 | TRUE | NA | 0.0000001 | TRUE |
| EMOTIONAL | 2591 | 990 | 21.783906 | 5 | 0.0005755 | TRUE | NA | 0.0028775 | TRUE |
| CARDIOVASCULAR | 2591 | 1072 | 14.972715 | 5 | 0.0104796 | TRUE | NA | 0.0419182 | TRUE |
| NERVOUS SYSTEM (REFLEXES) | 2591 | 603 | 8.868989 | 5 | 0.1144052 | TRUE | NA | 0.3432157 | FALSE |
| NOT SURE | 2591 | 72 | 8.266810 | 5 | 0.1421313 | TRUE | NA | 0.3432157 | FALSE |
| MOTOR (MUSCLES) | 2591 | 614 | 5.952049 | 5 | 0.3109128 | TRUE | NA | 0.3432157 | FALSE |
The reference year used in the logistic regression is 2019, so each odds ratio compares a given year against 2019.
ex: Compared with the reference year(2019), the odds of reporting gastrointestinal symptoms were significantly higher in 2023 (OR = 1.55, 95% CI: 1.08 to 2.23, p = 0.017), indicating approximately 55% higher odds of selecting gastrointestinal symptoms.
| Symptom | Term | OR | CI_Lower | CI_Upper | P_Value |
|---|---|---|---|---|---|
| SKIN | YEAR2020 | 0.8747987 | 0.5887327 | 1.2966200 | 0.5056762 |
| SKIN | YEAR2021 | 1.0508253 | 0.6370742 | 1.7786625 | 0.8492438 |
| SKIN | YEAR2022 | 0.6935552 | 0.4799859 | 0.9934046 | 0.0481768 |
| SKIN | YEAR2023 | 0.6969941 | 0.4820535 | 0.9991100 | 0.0517403 |
| SKIN | YEAR2024 | 0.1908436 | 0.1303020 | 0.2765657 | 0.0000000 |
| RESPIRATORY | YEAR2020 | 1.1090067 | 0.8481657 | 1.4506018 | 0.4495887 |
| RESPIRATORY | YEAR2021 | 1.0088384 | 0.7243221 | 1.4103125 | 0.9586765 |
| RESPIRATORY | YEAR2022 | 0.7488588 | 0.5829776 | 0.9606637 | 0.0231717 |
| RESPIRATORY | YEAR2023 | 0.9096922 | 0.7067181 | 1.1699397 | 0.4615257 |
| RESPIRATORY | YEAR2024 | 0.4339693 | 0.3189899 | 0.5886924 | 0.0000001 |
| GASTROINTESTINAL | YEAR2020 | 0.7366601 | 0.5230824 | 1.0338655 | 0.0782573 |
| GASTROINTESTINAL | YEAR2021 | 0.7871397 | 0.5178533 | 1.2088620 | 0.2673032 |
| GASTROINTESTINAL | YEAR2022 | 1.1805392 | 0.8324457 | 1.6723307 | 0.3502435 |
| GASTROINTESTINAL | YEAR2023 | 1.4713404 | 1.0232129 | 2.1201820 | 0.0373795 |
| GASTROINTESTINAL | YEAR2024 | 4.2052337 | 2.2769605 | 8.5298299 | 0.0000167 |
| CARDIOVASCULAR | YEAR2020 | 1.1489310 | 0.8857566 | 1.4909568 | 0.2957941 |
| CARDIOVASCULAR | YEAR2021 | 1.1282401 | 0.8144684 | 1.5603599 | 0.4665647 |
| CARDIOVASCULAR | YEAR2022 | 1.0191197 | 0.7949737 | 1.3071482 | 0.8812817 |
| CARDIOVASCULAR | YEAR2023 | 1.3093555 | 1.0231880 | 1.6773195 | 0.0324875 |
| CARDIOVASCULAR | YEAR2024 | 0.7536937 | 0.5491107 | 1.0304352 | 0.0780031 |
| EMOTIONAL | YEAR2020 | 0.8310971 | 0.6366026 | 1.0843138 | 0.1730759 |
| EMOTIONAL | YEAR2021 | 0.7325016 | 0.5200754 | 1.0254140 | 0.0719640 |
| EMOTIONAL | YEAR2022 | 1.0119809 | 0.7885973 | 1.2993577 | 0.9254871 |
| EMOTIONAL | YEAR2023 | 1.2928177 | 1.0094964 | 1.6574439 | 0.0422386 |
| EMOTIONAL | YEAR2024 | 0.7682305 | 0.5591148 | 1.0513564 | 0.1014163 |
| MOTOR (MUSCLES) | YEAR2020 | 1.0280374 | 0.7587497 | 1.3932488 | 0.8583156 |
| MOTOR (MUSCLES) | YEAR2021 | 0.9334990 | 0.6309051 | 1.3665455 | 0.7266087 |
| MOTOR (MUSCLES) | YEAR2022 | 1.0115938 | 0.7580976 | 1.3522293 | 0.9377116 |
| MOTOR (MUSCLES) | YEAR2023 | 1.2596891 | 0.9504878 | 1.6741412 | 0.1096204 |
| MOTOR (MUSCLES) | YEAR2024 | 0.8845597 | 0.6112598 | 1.2697642 | 0.5100665 |
| NERVOUS SYSTEM (REFLEXES) | YEAR2020 | 1.0275229 | 0.7598318 | 1.3898582 | 0.8599766 |
| NERVOUS SYSTEM (REFLEXES) | YEAR2021 | 0.8164619 | 0.5467571 | 1.2034057 | 0.3127176 |
| NERVOUS SYSTEM (REFLEXES) | YEAR2022 | 0.8944454 | 0.6683263 | 1.1982603 | 0.4535004 |
| NERVOUS SYSTEM (REFLEXES) | YEAR2023 | 1.2297056 | 0.9287694 | 1.6324028 | 0.1503337 |
| NERVOUS SYSTEM (REFLEXES) | YEAR2024 | 0.8441224 | 0.5827068 | 1.2123461 | 0.3638265 |
| NOT SURE | YEAR2020 | 1.6333733 | 0.8174264 | 3.3859533 | 0.1718676 |
| NOT SURE | YEAR2021 | 0.4805932 | 0.1093656 | 1.5095032 | 0.2562714 |
| NOT SURE | YEAR2022 | 0.6704256 | 0.2918170 | 1.5130325 | 0.3346583 |
| NOT SURE | YEAR2023 | 1.0545156 | 0.5087713 | 2.2361752 | 0.8870751 |
| NOT SURE | YEAR2024 | 0.9330593 | 0.3468406 | 2.3077276 | 0.8840707 |
| Symptom | Contrast | OddsRatio | CI_Lower | CI_Upper | P_Value |
|---|---|---|---|---|---|
| SKIN | YEAR2019 / YEAR2020 | 1.1431201 | 0.6337377 | 2.0619314 | 1.0000000 |
| SKIN | YEAR2019 / YEAR2021 | 0.9516330 | 0.4425914 | 2.0461431 | 1.0000000 |
| SKIN | YEAR2019 / YEAR2022 | 1.4418462 | 0.8372084 | 2.4831579 | 0.4817682 |
| SKIN | YEAR2019 / YEAR2023 | 1.4347324 | 0.8321910 | 2.4735391 | 0.4817682 |
| SKIN | YEAR2019 / YEAR2024 | 5.2398922 | 2.9849749 | 9.1982248 | 0.0000000 |
| SKIN | YEAR2020 / YEAR2021 | 0.8324873 | 0.3919896 | 1.7679935 | 1.0000000 |
| SKIN | YEAR2020 / YEAR2022 | 1.2613252 | 0.7453438 | 2.1345066 | 1.0000000 |
| SKIN | YEAR2020 / YEAR2023 | 1.2551020 | 0.7408508 | 2.1263137 | 1.0000000 |
| SKIN | YEAR2020 / YEAR2024 | 4.5838509 | 2.6558107 | 7.9115916 | 0.0000000 |
| SKIN | YEAR2021 / YEAR2022 | 1.5151285 | 0.7393250 | 3.1050137 | 0.7134761 |
| SKIN | YEAR2021 / YEAR2023 | 1.5076531 | 0.7350837 | 3.0921888 | 0.7134761 |
| SKIN | YEAR2021 / YEAR2024 | 5.5062112 | 2.6479346 | 11.4498150 | 0.0000000 |
| SKIN | YEAR2022 / YEAR2023 | 0.9950662 | 0.6189248 | 1.5998012 | 1.0000000 |
| SKIN | YEAR2022 / YEAR2024 | 3.6341547 | 2.2143601 | 5.9642874 | 0.0000000 |
| SKIN | YEAR2023 / YEAR2024 | 3.6521739 | 2.2227413 | 6.0008667 | 0.0000000 |
| RESPIRATORY | YEAR2019 / YEAR2020 | 0.9017078 | 0.6034349 | 1.3474146 | 1.0000000 |
| RESPIRATORY | YEAR2019 / YEAR2021 | 0.9912390 | 0.6021320 | 1.6317932 | 1.0000000 |
| RESPIRATORY | YEAR2019 / YEAR2022 | 1.3353652 | 0.9188329 | 1.9407231 | 0.2085456 |
| RESPIRATORY | YEAR2019 / YEAR2023 | 1.0992730 | 0.7537891 | 1.6031023 | 1.0000000 |
| RESPIRATORY | YEAR2019 / YEAR2024 | 2.3043103 | 1.4567855 | 3.6449059 | 0.0000013 |
| RESPIRATORY | YEAR2020 / YEAR2021 | 1.0992908 | 0.6664655 | 1.8132075 | 1.0000000 |
| RESPIRATORY | YEAR2020 / YEAR2022 | 1.4809290 | 1.0163457 | 2.1578786 | 0.0220146 |
| RESPIRATORY | YEAR2020 / YEAR2023 | 1.2191011 | 0.8338060 | 1.7824381 | 0.7549086 |
| RESPIRATORY | YEAR2020 / YEAR2024 | 2.5554957 | 1.6121597 | 4.0508135 | 0.0000000 |
| RESPIRATORY | YEAR2021 / YEAR2022 | 1.3471677 | 0.8349317 | 2.1736637 | 0.5399717 |
| RESPIRATORY | YEAR2021 / YEAR2023 | 1.1089888 | 0.6854698 | 1.7941799 | 1.0000000 |
| RESPIRATORY | YEAR2021 / YEAR2024 | 2.3246767 | 1.3450475 | 4.0177927 | 0.0000723 |
| RESPIRATORY | YEAR2022 / YEAR2023 | 0.8232002 | 0.5798978 | 1.1685829 | 0.7217384 |
| RESPIRATORY | YEAR2022 / YEAR2024 | 1.7256031 | 1.1150824 | 2.6703911 | 0.0026950 |
| RESPIRATORY | YEAR2023 / YEAR2024 | 2.0962131 | 1.3505863 | 3.2534828 | 0.0000101 |
| GASTROINTESTINAL | YEAR2019 / YEAR2020 | 1.3574782 | 0.8156097 | 2.2593491 | 0.3912863 |
| GASTROINTESTINAL | YEAR2019 / YEAR2021 | 1.2704225 | 0.6743738 | 2.3932920 | 0.8952026 |
| GASTROINTESTINAL | YEAR2019 / YEAR2022 | 0.8470706 | 0.5028371 | 1.4269603 | 0.8952026 |
| GASTROINTESTINAL | YEAR2019 / YEAR2023 | 0.6796524 | 0.3942749 | 1.1715869 | 0.2616563 |
| GASTROINTESTINAL | YEAR2019 / YEAR2024 | 0.2377989 | 0.0892970 | 0.6332615 | 0.0002177 |
| GASTROINTESTINAL | YEAR2020 / YEAR2021 | 0.9358696 | 0.5075357 | 1.7256949 | 0.8952026 |
| GASTROINTESTINAL | YEAR2020 / YEAR2022 | 0.6240031 | 0.3802613 | 1.0239797 | 0.0415494 |
| GASTROINTESTINAL | YEAR2020 / YEAR2023 | 0.5006728 | 0.2978166 | 0.8417034 | 0.0011126 |
| GASTROINTESTINAL | YEAR2020 / YEAR2024 | 0.1751770 | 0.0666893 | 0.4601480 | 0.0000018 |
| GASTROINTESTINAL | YEAR2021 / YEAR2022 | 0.6667629 | 0.3579670 | 1.2419377 | 0.3347062 |
| GASTROINTESTINAL | YEAR2021 / YEAR2023 | 0.5349814 | 0.2816931 | 1.0160172 | 0.0378302 |
| GASTROINTESTINAL | YEAR2021 / YEAR2024 | 0.1871810 | 0.0663951 | 0.5277001 | 0.0000291 |
| GASTROINTESTINAL | YEAR2022 / YEAR2023 | 0.8023563 | 0.4716493 | 1.3649453 | 0.8952026 |
| GASTROINTESTINAL | YEAR2022 / YEAR2024 | 0.2807309 | 0.1061894 | 0.7421632 | 0.0013785 |
| GASTROINTESTINAL | YEAR2023 / YEAR2024 | 0.3498831 | 0.1306979 | 0.9366501 | 0.0174641 |
| CARDIOVASCULAR | YEAR2019 / YEAR2020 | 0.8703743 | 0.5894303 | 1.2852265 | 1.0000000 |
| CARDIOVASCULAR | YEAR2019 / YEAR2021 | 0.8863362 | 0.5449363 | 1.4416215 | 1.0000000 |
| CARDIOVASCULAR | YEAR2019 / YEAR2022 | 0.9812390 | 0.6762667 | 1.4237431 | 1.0000000 |
| CARDIOVASCULAR | YEAR2019 / YEAR2023 | 0.7637345 | 0.5275511 | 1.1056568 | 0.4131932 |
| CARDIOVASCULAR | YEAR2019 / YEAR2024 | 1.3267989 | 0.8284717 | 2.1248709 | 0.7020278 |
| CARDIOVASCULAR | YEAR2020 / YEAR2021 | 1.0183392 | 0.6275949 | 1.6523632 | 1.0000000 |
| CARDIOVASCULAR | YEAR2020 / YEAR2022 | 1.1273759 | 0.7794226 | 1.6306641 | 1.0000000 |
| CARDIOVASCULAR | YEAR2020 / YEAR2023 | 0.8774783 | 0.6080340 | 1.2663241 | 1.0000000 |
| CARDIOVASCULAR | YEAR2020 / YEAR2024 | 1.5244005 | 0.9542138 | 2.4352999 | 0.1155386 |
| CARDIOVASCULAR | YEAR2021 / YEAR2022 | 1.1070732 | 0.6919054 | 1.7713563 | 1.0000000 |
| CARDIOVASCULAR | YEAR2021 / YEAR2023 | 0.8616759 | 0.5394965 | 1.3762560 | 1.0000000 |
| CARDIOVASCULAR | YEAR2021 / YEAR2024 | 1.4969477 | 0.8623660 | 2.5984936 | 0.4131932 |
| CARDIOVASCULAR | YEAR2022 / YEAR2023 | 0.7783369 | 0.5495119 | 1.1024480 | 0.4131932 |
| CARDIOVASCULAR | YEAR2022 / YEAR2024 | 1.3521669 | 0.8587541 | 2.1290790 | 0.5109442 |
| CARDIOVASCULAR | YEAR2023 / YEAR2024 | 1.7372515 | 1.1053582 | 2.7303754 | 0.0050468 |
| EMOTIONAL | YEAR2019 / YEAR2020 | 1.2032289 | 0.8076843 | 1.7924822 | 0.8653795 |
| EMOTIONAL | YEAR2019 / YEAR2021 | 1.3651848 | 0.8215975 | 2.2684216 | 0.6476763 |
| EMOTIONAL | YEAR2019 / YEAR2022 | 0.9881610 | 0.6799829 | 1.4360099 | 1.0000000 |
| EMOTIONAL | YEAR2019 / YEAR2023 | 0.7735043 | 0.5336812 | 1.1210978 | 0.4749755 |
| EMOTIONAL | YEAR2019 / YEAR2024 | 1.3016926 | 0.8115575 | 2.0878419 | 0.7099144 |
| EMOTIONAL | YEAR2020 / YEAR2021 | 1.1346011 | 0.6805321 | 1.8916371 | 1.0000000 |
| EMOTIONAL | YEAR2020 / YEAR2022 | 0.8212577 | 0.5625597 | 1.1989202 | 0.7595019 |
| EMOTIONAL | YEAR2020 / YEAR2023 | 0.6428571 | 0.4415081 | 0.9360311 | 0.0083582 |
| EMOTIONAL | YEAR2020 / YEAR2024 | 1.0818329 | 0.6720479 | 1.7414868 | 1.0000000 |
| EMOTIONAL | YEAR2021 / YEAR2022 | 0.7238294 | 0.4425259 | 1.1839512 | 0.5386287 |
| EMOTIONAL | YEAR2021 / YEAR2023 | 0.5665931 | 0.3470924 | 0.9249056 | 0.0093389 |
| EMOTIONAL | YEAR2021 / YEAR2024 | 0.9534919 | 0.5388772 | 1.6871130 | 1.0000000 |
| EMOTIONAL | YEAR2022 / YEAR2023 | 0.7827715 | 0.5520011 | 1.1100182 | 0.4749755 |
| EMOTIONAL | YEAR2022 / YEAR2024 | 1.3172880 | 0.8353255 | 2.0773314 | 0.6476763 |
| EMOTIONAL | YEAR2023 / YEAR2024 | 1.6828512 | 1.0694547 | 2.6480675 | 0.0097732 |
| Question | RespondentCount |
|---|---|
| ADDITIONAL_ALLERGIES | 2594 |
| AGE_AT_DIAGNOSIS | 2594 |
| DIAGNOSED_WITH_ALPHA_GAL_SYNDROME | 2594 |
| EXPOSED | 2594 |
| MEDICAL_INTERVENTIONS_FOR_ALPHA_GAL_SYNDROME | 2594 |
| OTHER_FAMILY_MEMBERS_DIAGNOSED_WITH_AGS | 2594 |
| OUTGROWN_OR_TOLERANT_TO_MAMMALIAN_INGREDIENTS | 2594 |
| POST_EXPOSURE_TIME | 2594 |
| PRIMARY_DIETARY_PREFERENCE_PREDIAGNOSIS | 2594 |
| REACTIONS_PER_YEAR_POST_DIAGNOSIS | 2594 |
| RESPONDENT_ID | 2594 |
| START_DATE | 2594 |
| YEAR | 2594 |
| AGS_SYMPTOMS | 2591 |
| WILLINGNESS_TO_USE_HEART_VALVE | 2587 |
| COMORBID_DIAGNOSIS | 2578 |
| EMOTIONAL_BEHAVIORAL | 2576 |
| GASTROINTESTINAL | 2575 |
| SKIN | 2571 |
| EASE_OF_IDENTIFYING_OTC_MEDICATIONS | 2569 |
| EASE_OF_IDENTIFYING_RX_MEDICATIONS | 2569 |
| EASE_OF_IDENTIFYING_VACCINES | 2566 |
| RESPIRATORY | 2562 |
| MAMMAL_INGREDIENT_REACTION | 2558 |
| AGE_AT_FIRST_ALLERGIC_REACTIONS | 2553 |
| CARDIOVASCULAR | 2549 |
| ACCESS_INFORMATION | 2535 |
| INDICATE_YOUR_WILLINGNESS_TO_USE_PRESCRIPTION_MEDICATIONS_WITH_MAMMAL_INGREDIENTS_THAT_HAVE_HAD_THE_ALPHA_GAL_CARBOHYDRATE_REMOVED_AND_VERIFIED_TO_BE_ALPHA_GAL_FREE | 2509 |
| USE_OF_GMO_PRODUCTS | 2509 |
| WILLINGNESS_TO_CONSUME_MODIFIED_MEAT_PRODUCTS | 2509 |
| NERVOUS_SYSTEM | 2505 |
| MOTOR | 2466 |
| TYPE_OF_HEALTHCARE_PROVIDER_DIAGNOSIS | 2362 |
| FINANCIAL_IMPACTS_OF_AGS | 2347 |
| MENTAL_HEALTH_CONCERNS | 2343 |
| AGE_RANGE | 2317 |
| GENDER | 2312 |
| ZIP_CODE | 2291 |
| HOUSEHOLD_INCOME | 2272 |
| RACE | 2269 |
| ADDITIONAL_TB_DIAGNOSIS | 2257 |
| EDUCATION | 2257 |
| ETHNICITY | 2248 |
| OTHER_THERAPIES_TO_REDUCES_REACTIONS | 2198 |
| IGE_LEVEL_FIRST_AGS_BLOOD_TEST_CLEAN | 1787 |
| ADDITIONAL_COMMENTS | 1665 |
| IGE_LEVEL_FIRST_AGS_BLOOD_TEST | 1646 |
| DATE_RECENT_AGS_BLOOD_TEST_OTHER | 982 |
| MEDICAL_INTERVENTIONS_FOR_ALPHA_GAL_SYNDROME_OTHER | 570 |
| EXPOSED_OTHER | 538 |
| ADDITIONAL_TB_DIAGNOSIS_OTHER | 432 |
| ADDITIONAL_ALLERGIES_OTHER | 410 |
| OUTGROWN_OR_TOLERANT_COMMENTS | 395 |
| MENTAL_HEALTH_CONCERNS_OTHER | 374 |
| GASTROINTESTINAL_OTHER | 267 |
| SKIN_OTHER | 263 |
| TYPE_OF_HEALTHCARE_PROVIDER_DIAGNOSIS_OTHER | 232 |
| CARDIOVASCULAR_OTHER | 222 |
| MOTOR_OTHER | 208 |
| EMOTIONAL_BEHAVIORAL_OTHER | 168 |
| NERVOUS_SYSTEM_OTHER | 165 |
| RESPIRATORY_OTHER | 149 |
| NUMBER_REACTIONS_PRIOR_TO_DIAGNOSIS | 39 |
| DATE_FIRST_AGS_BLOOD_TEST | 0 |
| DATE_RECENT_AGS_BLOOD_TEST | 0 |
START_DATE ranges from 2019-12-14 to 2024-12-27